Watch Ticker

Ocuphire Pharma, Inc. Common Stock

Go to Ocuphire Pharma, Inc. Common Stock Website

$1.17

(%)

Live

Previous Close

$1.17

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

Nasdaq

...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Vandana Singh - Ophthalmic Biopharmaceutical Ocuphire Pharma Shifts Focus To Gene Therapy Through Opus Genetics Stock Deal

Ocuphire Pharma announced the acquisition of Opus Genetics, a gene therapy company for inherited retinal diseases. The combined company will be renamed Opus Genetics and focus on gene therapy pipeline, while seeking a partner to advance the late-stage diabetic retinopathy program.

Related tickers: OCUP.

Read Full Article

Ocuphire Pharma, Inc. - Ocuphire Pharma Announces Publication of Full Phase 3 Results of Phentolamine Ophthalmic Solution 0.75% for Pharmacologically-Induced Mydriasis in Ophthalmology

Ocuphire Pharma announced the publication of full results from two Phase 3 clinical trials evaluating the safety and efficacy of Phentolamine Ophthalmic Solution 0.75% for the treatment of pharmacologically-induced mydriasis. The results demonstrated rapid reversal of pupil dilation with a favorable safety profile.

Related tickers: OCUP.

Read Full Article

Trending Tickers

Please sign in to view